CTLA-4 CT 60 A/G may affect the susceptibility of ITP, but both CTLA-4 + 49 A/G and CT60 A/G did not impact the response of patients with ITP to different lines of therapy. This evidence concerns the gene CTLA4 and autoimmune thrombocytopenic purpura.